These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17199809)

  • 1. Lessons from the sustainability movement: toward an integrative decision-making framework for nanotechnology.
    Meaney ME
    J Law Med Ethics; 2006; 34(4):682-8. PubMed ID: 17199809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Science, ethics, and the "problems" of governing nanotechnologies.
    Hogle LF
    J Law Med Ethics; 2009; 37(4):749-58. PubMed ID: 20122114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.
    Nelson KC; Andow DA; Banker MJ
    J Law Med Ethics; 2009; 37(4):732-48. PubMed ID: 20122113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and environmental ethics.
    Tomoki K
    J Int Bioethique; 2011; 22(1):137-43, 214-5. PubMed ID: 21850974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mega-sized concerns from the nano-sized world: the intersection of nano- and environmental ethics.
    Attia P
    Sci Eng Ethics; 2013 Sep; 19(3):1007-16. PubMed ID: 23224702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stirring the pot in environmental health.
    Hood E
    Environ Health Perspect; 2005 Jan; 113(1):A28-31. PubMed ID: 15643721
    [No Abstract]   [Full Text] [Related]  

  • 10. Techno-Cultural Factors Affecting Policy Decision-Making: A Social Network Analysis of South Korea's Local Spatial Planning Policy.
    Park ES; Lee AY
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using trading zones and life cycle analysis to understand nanotechnology regulation.
    Wardak A; Gorman ME
    J Law Med Ethics; 2006; 34(4):695-703. PubMed ID: 17199811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBA and Precaution: Policy-Making about Emerging Technologies.
    Kaebnick GE; Gusmano MK
    Hastings Cent Rep; 2018 Jan; 48 Suppl 1():S88-S96. PubMed ID: 29453836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from San Francisco: health impact assessments have advanced political conditions for improving population health.
    Bhatia R; Corburn J
    Health Aff (Millwood); 2011 Dec; 30(12):2410-8. PubMed ID: 22147870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the Precautionary Principle: incorporating science, technology, fairness, and accountability in environmental, health, and safety decisions.
    Ashford NA
    Int J Occup Med Environ Health; 2004; 17(1):59-67. PubMed ID: 15212207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will nanotechnology make the world a better place?
    Parr D
    Trends Biotechnol; 2005 Aug; 23(8):395-8. PubMed ID: 15967522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals.
    Ritrovato M; Faggiano FC; Tedesco G; Derrico P
    Value Health; 2015 Jun; 18(4):505-11. PubMed ID: 26091605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles for planning and conducting comparative effectiveness research.
    Luce BR; Drummond MF; Dubois RW; Neumann PJ; Jönsson B; Siebert U; Schwartz JS
    J Comp Eff Res; 2012 Sep; 1(5):431-40. PubMed ID: 24236420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redesigning the architecture of policy-making: Engaging with Māori on nanotechnology in New Zealand.
    Munshi D; Kurian PA; Morrison T; Morrison SL
    Public Underst Sci; 2016 Apr; 25(3):287-302. PubMed ID: 25193966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking evidence from health technology assessments to policy and decision making: the Alberta model.
    Borowski HZ; Brehaut J; Hailey D
    Int J Technol Assess Health Care; 2007; 23(2):155-61. PubMed ID: 17493300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.